What happens when you come off Mounjaro?

Does appetite come back when you stop Mounjaro?

Yes, and for most people it returns fairly quickly. Tirzepatide works by activating GIP and GLP-1 receptors, which between them slow gastric emptying, reduce hunger signalling and increase the sense of fullness after eating. Once you take your last dose, plasma levels fall over roughly one to two weeks, and those receptor effects fade with them. You can read more about what happens when you stop Mounjaro, including how quickly appetite and hunger signalling typically reassert themselves for most people.

This is not a character flaw or a failure of willpower. The biology that drove appetite before treatment is still there; the medicine was suppressing it. When the suppression lifts, the underlying drive reasserts itself. Understanding that framing matters, because it shapes what you can realistically do about it. The NHS's guidance on tirzepatide reinforces that this medicine works alongside dietary change and increased activity, those habits are what you retain when the prescription ends.

If your appetite returning feels overwhelming rather than manageable, that is worth discussing with your prescriber before you stop, not after. Our clinical team reviews exactly this kind of situation every week.

How much weight do people regain after coming off Mounjaro?

The honest answer is: often quite a lot, and often within the first few months. The SURMOUNT-1 extension data for tirzepatide align with what was seen in semaglutide cessation studies, roughly half to two-thirds of lost weight can return within a year for people who stop without any behavioural or pharmacological support. The trial populations that maintained the most weight loss after stopping were those who had embedded consistent dietary and activity habits during the treatment period.

None of this means stopping is always the wrong call. Circumstances change, pregnancy, surgery, cost, personal choice. But it does mean that coming off Mounjaro is worth planning rather than doing abruptly. If weight management is a long-term health priority for you, that conversation belongs in a clinical review, not as an afterthought on the last pen. You can read more about what stopping Mounjaro involves in our dedicated guide.

One practical note: some people keep a pen stored in the fridge door for weeks past their intended last dose, uncertain whether to continue. That uncertainty is itself a signal to talk to your prescriber rather than making the call alone.

Is there a right way to come off Mounjaro?

There is no mandatory taper with tirzepatide in the way there is with, say, corticosteroids. You will not experience a physiological withdrawal syndrome if you stop abruptly. What you lose is the pharmacological appetite suppression, and that loss can be managed more or less well depending on what else is in place.

Clinically, the strongest predictor of maintaining weight loss after stopping any GLP-1 or dual-agonist treatment is what was built during treatment: consistent protein intake, hydration, sustainable activity, and a realistic relationship with portion sizes. None of those require a prescription. A prescriber can also discuss whether a planned pause makes more sense than full cessation, or whether continuing on a lower maintenance dose is appropriate for your situation.

For context on how the medicine works during treatment, our page on what happens when you take Mounjaro covers the mechanism in more detail. If you are thinking about stopping because of side effects, cost, or supply questions, that is also a conversation worth having before you act, our team is available seven days a week.

What should you actually do if you're planning to stop?

Tell your prescriber first. This sounds obvious, but a meaningful number of people simply stop filling their next repeat and leave it there. If you are on treatment through a regulated service, your prescriber can document the decision, note your current weight and health markers, and give you a realistic picture of what to expect. That record also matters if you want to restart in the future, evidence of previous treatment and outcomes can inform that decision.

On the practical side, the NICE appraisal of tirzepatide (TA1026) notes that continuing treatment is reviewed if weight loss falls below 5% after six months at the highest tolerated dose. That same logic applies in reverse: stopping when things are going well is a decision worth stress-testing. Are the lifestyle changes holding independently? Is the weight loss at a point where stopping feels sustainable? A clinical review (not a solo decision) is the right setting for those questions.

If you are considering starting or restarting treatment, our Mounjaro service explains what is involved, and our free consultation is the first step, where a GPhC-registered prescriber reads your answers the same day, and there is no obligation to proceed. If you would like detail on how to administer the treatment correctly, our guide to the Mounjaro injection walks through the process step by step.